PortalPublikationenMonitoring of loss of heterozygosity in serum microsatellite...

Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.

Standard

Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. / Rawnaq, Tamina; Schwarzenbach, Heidi; Schurr, Paulus; Freise, Kathrin; Brandl, Stephan; Izbicki, Jakob R.; Kaifi, Jussuf.

in: J SURG RES, Jahrgang 169, Nr. 1, 1, 2011, S. 31-35.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Rawnaq, T, Schwarzenbach, H, Schurr, P, Freise, K, Brandl, S, Izbicki, JR & Kaifi, J 2011, 'Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.', J SURG RES, Jg. 169, Nr. 1, 1, S. 31-35. <http://www.ncbi.nlm.nih.gov/pubmed/20417938?dopt=Citation>

APA

Rawnaq, T., Schwarzenbach, H., Schurr, P., Freise, K., Brandl, S., Izbicki, J. R., & Kaifi, J. (2011). Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. J SURG RES, 169(1), 31-35. [1]. http://www.ncbi.nlm.nih.gov/pubmed/20417938?dopt=Citation

Vancouver

Rawnaq T, Schwarzenbach H, Schurr P, Freise K, Brandl S, Izbicki JR et al. Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. J SURG RES. 2011;169(1):31-35. 1.

Bibtex

@article{1c94e9fddf99426bb9b6de6f4e14f9eb,
title = "Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.",
abstract = "Patients with gastrointestinal stromal tumors (GIST) harbor increased levels of circulating tumor DNA in their peripheral blood. In the current study, the aim was to investigate whether the frequency of loss of heterozygosity (LOH) on cell-free DNA in blood may reflect tumor stage and recurrent disease of these patients.",
author = "Tamina Rawnaq and Heidi Schwarzenbach and Paulus Schurr and Kathrin Freise and Stephan Brandl and Izbicki, {Jakob R.} and Jussuf Kaifi",
year = "2011",
language = "English",
volume = "169",
pages = "31--35",
journal = "J SURG RES",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence.

AU - Rawnaq, Tamina

AU - Schwarzenbach, Heidi

AU - Schurr, Paulus

AU - Freise, Kathrin

AU - Brandl, Stephan

AU - Izbicki, Jakob R.

AU - Kaifi, Jussuf

PY - 2011

Y1 - 2011

N2 - Patients with gastrointestinal stromal tumors (GIST) harbor increased levels of circulating tumor DNA in their peripheral blood. In the current study, the aim was to investigate whether the frequency of loss of heterozygosity (LOH) on cell-free DNA in blood may reflect tumor stage and recurrent disease of these patients.

AB - Patients with gastrointestinal stromal tumors (GIST) harbor increased levels of circulating tumor DNA in their peripheral blood. In the current study, the aim was to investigate whether the frequency of loss of heterozygosity (LOH) on cell-free DNA in blood may reflect tumor stage and recurrent disease of these patients.

M3 - SCORING: Journal article

VL - 169

SP - 31

EP - 35

JO - J SURG RES

JF - J SURG RES

SN - 0022-4804

IS - 1

M1 - 1

ER -